These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 32516966)
1. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization. Tilocca B; Pieroni L; Soggiu A; Britti D; Bonizzi L; Roncada P; Greco V Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516966 [TBL] [Abstract][Full Text] [Related]
2. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics. Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767 [TBL] [Abstract][Full Text] [Related]
3. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Spielman LJ; Gibson DL; Klegeris A Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473 [TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Luan H; Wang X; Cai Z Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504 [TBL] [Abstract][Full Text] [Related]
5. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration. Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373 [TBL] [Abstract][Full Text] [Related]
6. Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy. Boeri L; Donnaloja F; Campanile M; Sardelli L; Tunesi M; Fusco F; Giordano C; Albani D Neurobiol Dis; 2022 Mar; 164():105614. PubMed ID: 35017031 [TBL] [Abstract][Full Text] [Related]
7. The human gut microbiome and its dysfunctions through the meta-omics prism. Mondot S; Lepage P Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826 [TBL] [Abstract][Full Text] [Related]
8. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Singh N; Singh V; Rai SN; Mishra V; Vamanu E; Singh MP Biomed Pharmacother; 2022 Dec; 156():113958. PubMed ID: 36411639 [TBL] [Abstract][Full Text] [Related]
9. Advancing functional and translational microbiome research using meta-omics approaches. Zhang X; Li L; Butcher J; Stintzi A; Figeys D Microbiome; 2019 Dec; 7(1):154. PubMed ID: 31810497 [TBL] [Abstract][Full Text] [Related]
10. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders. Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074 [TBL] [Abstract][Full Text] [Related]
11. An Organ-On-A-Chip Engineered Platform to Study the Microbiota-Gut-Brain Axis in Neurodegeneration. Raimondi MT; Albani D; Giordano C Trends Mol Med; 2019 Sep; 25(9):737-740. PubMed ID: 31422037 [TBL] [Abstract][Full Text] [Related]
12. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219 [TBL] [Abstract][Full Text] [Related]
13. MetaComp: comprehensive analysis software for comparative meta-omics including comparative metagenomics. Zhai P; Yang L; Guo X; Wang Z; Guo J; Wang X; Zhu H BMC Bioinformatics; 2017 Oct; 18(1):434. PubMed ID: 28969605 [TBL] [Abstract][Full Text] [Related]
14. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study. Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534 [TBL] [Abstract][Full Text] [Related]
15. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304 [TBL] [Abstract][Full Text] [Related]
16. Multi-omics approach to elucidate the gut microbiota activity: Metaproteomics and metagenomics connection. Guirro M; Costa A; Gual-Grau A; Mayneris-Perxachs J; Torrell H; Herrero P; Canela N; Arola L Electrophoresis; 2018 Jul; 39(13):1692-1701. PubMed ID: 29427518 [TBL] [Abstract][Full Text] [Related]
17. Metaproteomics: A strategy to study the taxonomy and functionality of the gut microbiota. Wang Y; Zhou Y; Xiao X; Zheng J; Zhou H J Proteomics; 2020 May; 219():103737. PubMed ID: 32198072 [TBL] [Abstract][Full Text] [Related]
18. Studying the human gut microbiota in the trans-omics era--focus on metagenomics and metabonomics. Tuohy KM; Gougoulias C; Shen Q; Walton G; Fava F; Ramnani P Curr Pharm Des; 2009; 15(13):1415-27. PubMed ID: 19442166 [TBL] [Abstract][Full Text] [Related]
19. Molecular ecological tools to decipher the role of our microbial mass in obesity. Hermes GD; Zoetendal EG; Smidt H Benef Microbes; 2015 Mar; 6(1):61-81. PubMed ID: 24902956 [TBL] [Abstract][Full Text] [Related]
20. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Pellegrini C; Antonioli L; Colucci R; Blandizzi C; Fornai M Acta Neuropathol; 2018 Sep; 136(3):345-361. PubMed ID: 29797112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]